A Single-Dose, Open-Label, Randomized, Crossover Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation Under Fasted Condition in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 31 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jun 2011 Actual initiation date (May 2011) added as reported by ClinicalTrials.gov.
- 16 Jun 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.